Moreover, activation of OCLs by RANKL injection results in a release of MCPs from the endosteal region and a decreased number of dormant MCPs in the BM, indicating that OCL control reactivation of dormant myeloma cells by remodeling the endosteal niche (15) as described for HSCs (12). Here, TNFSF11 is linked to plasma cell myeloma.